~3 spots leftby Apr 2026

Vagus Nerve Stimulation for Neuromodulation

(VNS-EPS Trial)

Recruiting in Palo Alto (17 mi)
SE
Overseen byStavros E Mountantonakis, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Northwell Health
No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial uses a device to send electrical pulses to the ear to affect heartbeats. It targets healthy people already having a heart study to see how this stimulation changes their heart's electrical signals.

Research Team

SE

Stavros E Mountantonakis, MD

Principal Investigator

Northwell Health

Eligibility Criteria

This trial is for individuals needing an electrophysiological study (EPS) to check their heart's electrical system or to investigate rapid heartbeats. It's not open to those who've had previous EPS with ablation, known conduction issues in the heart, are pregnant, have certain cardiovascular diseases, a history of vagotomy, skin conditions on the tragus, or active implanted medical devices.

Inclusion Criteria

I need a heart test to check for abnormal rhythms.

Exclusion Criteria

Pregnant women
My skin on the tragus is broken or cracked.
Patients with an active implantable medical device, such as a cardiac pacemaker, hearing aid implant, or any implanted metallic, implanted vagus nerve stimulator or electronic device.
See 6 more

Treatment Details

Interventions

  • Auricular Vagal Nerve Stimulation (Device)
Trial OverviewThe study tests auricular vagus nerve stimulation (aVNS), a non-invasive method that may affect the cardiac conduction system. Participants will undergo this stimulation during their scheduled EPS procedure at a single center in a pilot and prospective setup.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Auricular Vagal Nerve StimulationExperimental Treatment1 Intervention
Patients will undergo a standard EPS with 4 catheters. Following the standard EPS, patients will be hooked up a Parasym device to provide transcutaneous electrical stimulation to the auricular branch of the vagus nerve, EPS will be repeated.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwell Health

Lead Sponsor

Trials
481
Recruited
470,000+
Michael Dowling profile image

Michael Dowling

Northwell Health

Chief Executive Officer since 2002

Bachelor's and Master's degrees from University College Cork, Ireland

Dr. David Battinelli profile image

Dr. David Battinelli

Northwell Health

Chief Medical Officer since 2022

MD from Georgetown University School of Medicine

University of Oklahoma

Collaborator

Trials
484
Recruited
95,900+
Dr. Scott Rollins profile image

Dr. Scott Rollins

University of Oklahoma

Chief Executive Officer since 2016

PhD in Immunology from the University of Oklahoma

Dr. Ondria Gleason profile image

Dr. Ondria Gleason

University of Oklahoma

Chief Medical Officer

MD from the University of Oklahoma College of Medicine